Cite
HARVARD Citation
Katlama, C. et al. (2020). Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors' response. Journal of antimicrobial chemotherapy. pp. 3699-3700. [Online].